Valuation: Viatris Inc.

Capitalization 1.57TCr 1.34TCr 1.24TCr 1.16TCr 2.17TCr 1,45900Cr 2.21TCr 15TCr 5.68TCr 70TCr 5.89TCr 5.76TCr 2,49600Cr P/E ratio 2026 *
45.9x
P/E ratio 2027 * 21.1x
Enterprise value 2.77TCr 2.36TCr 2.18TCr 2.06TCr 3.83TCr 2,57800Cr 3.91TCr 26TCr 10TCr 1,23800Cr 10TCr 10TCr 4,41000Cr EV / Sales 2026 *
1.89x
EV / Sales 2027 * 1.76x
Free-Float
96.32%
Yield 2026 *
3.78%
Yield 2027 * 3.87%

Last Transcript: Viatris Inc.

1 day-1.03%
1 week+0.22%
Current month-0.30%
1 month-3.58%
3 months+5.56%
6 months+38.30%
Current year+8.19%
1 week 13.12
Extreme 13.12
13.78
1 month 12.87
Extreme 12.87
13.97
Current year 12.19
Extreme 12.19
16.47
1 year 7.34
Extreme 7.335
16.47
3 years 6.85
Extreme 6.85
16.47
5 years 6.85
Extreme 6.85
16.47
10 years 6.85
Extreme 6.85
50.4
Manager TitleAgeSince
Chief Executive Officer 63 01/04/2023
Director of Finance/CFO 43 01/01/2024
Chief Tech/Sci/R&D Officer - 15/12/2023
Director TitleAgeSince
Director/Board Member 78 16/11/2020
Director/Board Member 78 16/11/2020
Director/Board Member 62 16/11/2020
Change 5d. change 1-year change 3-years change Capi.($)
-1.03%+0.22%+78.65%+35.92% 1.57TCr
-1.65%+0.42%+28.27%+158.07% 84TCr
-1.18%-1.88%+57.16%+45.16% 57TCr
-2.10%-0.43%+18.79%+28.85% 37TCr
-0.09%0.00%+30.43%+16.21% 32TCr
-0.30%-0.56%+52.18%+30.95% 32TCr
-1.03%+0.46%+53.35%+7.94% 30TCr
-0.34%-1.17%+41.43%+40.20% 29TCr
-1.29%+0.89%+22.74%+39.61% 19TCr
-2.18%-0.52%+34.12%+68.39% 17TCr
Average -1.12%+0.27%+41.71%+47.13% 33.94TCr
Weighted average by Cap. -1.18%+0.00%+38.16%+64.41%

Financials

2026 *2027 *
Net sales 1.46TCr 1.25TCr 1.15TCr 1.09TCr 2.02TCr 1,36100Cr 2.07TCr 14TCr 5.3TCr 65TCr 5.49TCr 5.38TCr 2,32900Cr 1.49TCr 1.27TCr 1.17TCr 1.11TCr 2.06TCr 1,38500Cr 2.1TCr 14TCr 5.39TCr 67TCr 5.59TCr 5.47TCr 2,37000Cr
Net income 18Cr 16Cr 15Cr 14Cr 26Cr 1.72TCr 26Cr 170.6Cr 67Cr 823.79Cr 69Cr 68Cr 2.94TCr 59Cr 51Cr 47Cr 44Cr 82Cr 5.53TCr 84Cr 550.28Cr 215.31Cr 2.66TCr 223.27Cr 218.54Cr 9.47TCr
Net Debt 1.2TCr 1.02TCr 948.37Cr 892.97Cr 1.66TCr 1,11900Cr 1.7TCr 11TCr 4.35TCr 54TCr 4.51TCr 4.42TCr 1,91400Cr 1.06TCr 900.91Cr 833.76Cr 785.05Cr 1.46TCr 98TCr 1.49TCr 9.78TCr 3.83TCr 47TCr 3.97TCr 3.88TCr 1,68300Cr
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s ARV franchise. The Company’s portfolio comprises approved molecules across a range of key therapeutic areas, including globally recognized iconic and key brands and generics, including complex products. The Company operates manufacturing sites across worldwide that produce oral solid doses, injectables and complex dosage forms.
Employees
30,000
Date Price Change Volume
10/26/10 13.47 $ -1.03% 65,39,707
09/26/09 13.61 $ +0.29% 57,38,737
08/26/08 13.57 $ +3.12% 66,29,401
07/26/07 13.16 $ -1.86% 1,16,21,406
06/26/06 13.41 $ -0.22% 86,17,686
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
13.47USD
Average target price
15.72USD
Spread / Average Target
+16.72%

Quarterly revenue - Rate of surprise